Search

The article focuses on the importance of biotechnology as a general-purpose technology that can transform society, economy, and national security. Topics discussed include the emergence of artificial intelligence, advanced networks, and microelectronics as major fronts in an international technology competition between democratic and authoritarian systems.

Specialists in food analysis are increasingly interested in taking advantage of methods that harness the power of ultrahigh-pressure liquid chromatography (UHPLC) and high-resolution mass spectrometry (HRMS). Jon Wong of the Center for Food Safety and Applied Nutrition at the U.S. Food and Drug Administration has been developing such methods for a variety of types of analysis. In this interview, he talks to LCGC about the work to develop these methods and the advantages of their use. [ABSTRACT FROM AUTHOR]

The article focuses on the biotechnology process introduced by the German start-up Numaferm. It discusses how the process could reduce the high costs needed to manufacture peptides and thus, it puts forth a challenge to peptide manufacturers like Bachem, CordenPharma and Polypeptide Laboratories. It talks about using a transport compound in the host bacteria Escherichia coli during peptide fermentation.

The article discusses the use of biolayer interferometry on the measurement of the fragment antigen-binding (FAB) fragment in fermentation. A table is presented on protein classes and location, along with their advantages and disadvantages. Also explored are biosensor types based on different chemistries.

The article discusses the topic of drug testing by the drug developers in order to study the distribution of the drugs. It informs that the biotechnology company Genentech has tested the drug candidate focusing on the lung tissue, where the assaying resulted on the drug being potent. The development process and the discovery in the drugs is possible because of the technique of imaging mass spec used by the researchers and biotechnology companies.

The article informs that the White House has released a new executive order that mandates the drafting of an inter-agency report on how to strengthen the biotechnology and manufacturing industry.

The article discusses the use of biotechnology in developing terpenes into useful products. The author offers details on the aromatic compounds known as terpenes which are commonly found in oranges, roses, and other plants, and highlights the research conducted by biochemist Matthew Styles and Marc Hutchby in developing terpenes into chemical feedstocks. The processes involved in the transformation of terpenes into useful products through catalysis.

The article looks at the aspects of bioeconomy including the challenges in introducing bio-based products and the realisation of success and opportunities for the companies. Topics include the economic potential of bio-based feedstocks such as national fuel security, the several approaches adopted by companies to find opportunities in the market considering various factors such as logistics, technologies, and regulations, and the advantages of the adoptation of bio-base economic approach.

The article offers information on the advantages of paper chemicals and their various categories which includes pulp making chemicals, paper making chemicals and pollution control chemicals. Topics discussed include impact of advancements in biotechnology, low cost production of paper chemicals and role of sizing agents in paper industry.

Reports that when space shuttle orbiter Discovery return to earth on November 7, 1998, it will have a collection of commercial biotechnology information, solar and ultraviolent astronomy images and technology data to aid the Hubble Space Telescope and International Space Station. Identification of the crew aboard Discovery; Significance of the presence of former Mercury astronaut and Senator John H. Glenn, Jr. among the flight crew; Details on the flight.

The article reports on the results of the IOTA trial conducted by Aurion Biotech to assess the effectiveness of corneal endothelial therapy in treating patients with corneal endothelial disease. The therapy was developed by a team led by Doctor Shigeru Kinoshita of Kyoto Prefecture University of Medicine in Japan. Also cited are the potential benefits of the therapy like the high supply of corneal endothelial cells and patient-friendly procedure.

The article presents the discussion on alternative proteins and oils for fish feeding attests to the growing market. Topics include innovations in feed reducing reliance on capture fisheries for feed ingredients; enabling the French biotechnology company for producing insect protein with a lower footprint; and replacing a ton of soy protein which being a widely used protein alternative to fishmeal.

The article reports that Pfeiffer Vacuum expands the series of explosion-proof OktaLine ATEX Roots pumps. It mentions OktaLine Roots pumps from Pfeiffer Vacuum are ideal for processes in potentially explosive environments or for evacuating explosive gases. It also mentions area of ​​application extends from the chemical, biotechnology and pharmaceutical industries to industrial applications such as vacuum furnaces or heat treatment.

Se anuncia el primer aniversario de SEMBRYO, un laboratorio de biotecnología, y el Laboratorio de Mejoramiento Genético Ganadero en Perú.

The article offers information on the creation of new ingredients with the help of plants and technological advancements. The popularity of botanical ingredients derived from plants including soy, pomegranate and green tea used in skin care industry mentioned. The synergistic effects of the botanical extracts and the challenges scientists face in extracting these compounds is mentioned. An overview of Zeta Fraction technology that helps in overcoming these challenges is discussed.

The article reports on biotechnology discoveries that look to replace animals in medical research. Topics discussed include the British government's initiative to promote the uptake of reduction, replacement and refinement of the use of animals in research, the 576,000 animals used in immunology research between 2012 and 2014, and the number of primates involved in safety testing of human medicines. Also mentioned is the driver for replacing animals in testing.

The article discusses how Southeast Asian nations are now encouraging biotechnology innovation by investing in research and development (R&D) with special reference to Thailand. Topics discussed include fostering innovation-based life sciences by the government of Thailand, establishing government and academic research labs to provide foreign-educated Thai scientists with viable career options in their home country and funding by the government to launch firms to promote life sciences.

The article discusses the results of studies by trade organization Biotechnology Innovation Organization (BIO) and consulting firm McKinsey & Co. which show the cumulative approval for the clinical trials of drugs including biologics and small molecules. Topics include oncology drugs with the lowest success in passing Phase I approval, the higher rate of approval when biomarkers are involved in selecting patients, and the types of drugs most likely to gain approval.

The article focuses on aspects of the developments in biotechnology for agriculture and the healthcare industry for manufacturers starting in 2014. A prediction that companies that develop safe biotechnological applications will gain profits is made. Particular focus is given to the possibility that biotechnology will help mitigate many global problems, including disease, pollution and hunger, and how it motivates biotechnology firms to improve their work.

The article profiles several biotechnology companies including Agilent Technologies Inc., Bruker Daltonics Inc., and Chem Service Inc. (CSI). It mentions the net revenue of Agilent and the company's goal to lead analytical chemistry and life science research laboratories. It cites a variety of innovative mass spectrometry systems provided by Bruker Daltonics which include drug metabolism studies. It states the products of CSI which include ultraviolet inhibitors, surfactants, and plasticizers.

The article offers an outlook for Brazil's chemical industry as of September 2013 following the economic slowdown. It notes that the industry remained the fourth largest contributor to the 2012 economy. It details challenges such as expensive raw materials, the lack of investment in the industry, in research and development, and in transport infrastructure. It also talks about specific areas like basic and intermediate petrochemicals, paints and coatings, specialty chemicals and biotechnology.

The article inform Biotechnology play a key role in the DeKalb, Asgrow and Deltapine product lines, ranging from the new ThryvOn technology for cotton to Acceleron Seed Applied Solutions for corn to Asgrow XtendFlex Soybeans. Topic include Jon Riley, Bayer North America cotton launch lead, gave an update on Bayer's new Bollgard3 ThryvOn cotton with XtendFlex Technology that was unveiled by the company in December at the Deltapine NPE (New Product Evaluator) summit in New Orleans.

The article discusses the need for governments, scientists, and inventors to bolster cooperative response to intellectual property (IP) amidst the COVID-19 pandemic. Also cited are the adverse effects of legal actions on the ability of the public to benefit from newly developed medicines and technologies, and some collaborative programs like the World Health Organization's (WHO) voluntary COVID-19 Technology Access Pool.

The article focuses on the role on nanotechnology in medical science. It is noted that the world in the midst of another explosion in medical technology with new challenges, ranging from antibiotic-resistant bacteria to scarce donor organs. It is mentioned that researchers have made enormous progress over the past decade to build tissues and organs. It is stated that natural designs could be altered with the sue of nanotechnology as it act like a reinforcement for synthetic tissues to provide them the strength, stiffness, and viscoelastic performance of natural membranes.

Several tables are presented which lists the topics of technical programs at the American Chemical Society Meeting to be held in New Orleans, Louisiana from April 7-11, 2013 including "Chemistry of Energy & Food Plenary," "Value Creation in Biotechnology," and "Advances in Analytical Spectroscopy."

The article presents 2012 news on libraries and information technology. The company Gartner Inc. has reported that global use of cloud services are expected to grow 19.6% and surpass $109 billion by the end of 2012.The Netherlands Organisation for Scientific Research announced that it has signed up as members with BioMed Central Ltd. and SpringerOpen open access journals. Qatar National Library announced that it has partnered with Innovative Interfaces, Inc. to translate resources into Arabic.

The article informs about decisions taken by the pharmaceutical industry in the U.S. regarding the drug repositioning or drug reuse. This decision has been taken for clinical development and business expansion. This technology is spreading among government agencies, small biotech firms and non-profit organizations. A table containing information about drug compounds including bleomycin, histrelin and cycloserine which have been approved by the U.S. Food and Drug Administration is presented.

The article discusses the highlights of the national meeting held by the American Chemical Society (ACS) in 2012. At the meeting, ACS tackled various issues relevant to biotechnology and chemistry, particularly the development of drugs for hepatitis, migraine, cancer and type 2 diabetes. Topics discussed include the structure of GS-9620, the BMS-791325 hepatitis C drug and the structure of GSK2636771 cancer drug from GlaxoSmithKline.

This section offers news briefs relevant to the information industry compiled as of January 2016. Academic publisher De Gruyterhas introduced a pricing model to prevent the double payment for open access publications that appear in hybrid journals. The U.S. Government Publishing Office has teamed up with the Natioal Archives' Office of the Federal Register to make issue of the "Federal Register" digitally available to the public.

The article presents the second part of a two-part series focusing on the use of ultrahigh-pressure liquid chromatography (UHPLC) in biotechnology. It notes the four major applications areas of biotechnology where UHPLC is vital including peptide mapping, amino acid analysis and glycoprofiling. Furthermore, it cites the significance of size-exclusion chromatography (SEC) in biotechnology, as well as the application of ion-exchange chromatography (IEC) in biopharmaceutical characterizations.

The article reports that drug developers and biotechnology companies are boosting their quality control (QC) and quality assurance (QA) teams as the regulatory environment grows more global and complex. Some companies maintain their staffing levels in QC and QA while others recruit QC scientists and QA experts. Some functions of the new recruits are monitoring the rising volume of drug ingredients being outsourced and leveraging analytical techniques.

The article offers an outlook on the employment opportunities for chemical engineers at biotechnology companies, particularly those interested in process development, in the wake of economic challenges facing the U.S. chemical industry. Chemical engineers at Bayer HealthCare fill in several process development roles such as in the development of cell culture processes. Ethanol producer Poet offers jobs in the area of research and development, design and construction, while Genomatica involves engineers in fermentation process for renewable feedstocks.

Information about the Isranalytica 2011, the 14th annual conference organized and administered by the Israel Analytical Chemistry Society, held from February 7 to 8, 2011 in Tel Aviv, Israel is presented. The conference involves sessions of various topics on biotechnology including peptides and protein analysis, pharmaceutical analysis, and mass spectrometry. Participants include scientists from academia, government organizations, and the pharmaceutical, chemical and biological industries.

The article discusses the development of an experimental bioelectronic device by the Feinstein Institute for Medical Research which could benefit patients with rheumatoid arthritis and inflammatory bowel disease. Topics explored include the statement issued by Feinstein chief executive officer (CEO) Kevin Tracey regarding the therapeutic potential of bioelectronic devices, the possible use of this device instead of medications, and the cost of rheumatoid arthritis treatment options. INSET: The Rheumatoid Arthritis Drug Problem.

This section provides news briefs on the information services industry as of December 2010. Serials Solutions has enhanced its 360 services suite for discovery. ISYS Search Software plans to update its text extraction, printing and viewing platform. The Institute of Electrical and Electronics Engineers (IEEE) plans to introduce its IEEE eLearning Library.

The article considers the market potential of producing chemicals from renewable material. McKinsey & Company forecasts that the international biobased chemicals and pharmaceuticals market will post 220 billion U.S. dollars-430 billion U.S. dollars by 2020. According to Myriant Technologies Founder, Chairman and Chief Executive Officer (CEO) Stephen Gatto, in order to be successful biotechnology companies should meet a mix of market demands and technological innovations. Several bioprocesses are less expensive compared to petroleum-based production.

The article discusses the regulatory guidance, scientific challenges, and the opportunity that biosimilars provide to drug manufacturers, regulators and patients in the U.S. It suggests that the increasing cost of health care and understanding of the factors that play a role in biotechnological therapeutic drugs manufacturing have paved the way for the biosimilars approval. It provides a definition of biosimilars and further explores existing scientific challenges.

The article focuses on the "Feeding the World Today and Tomorrow: The Importance of Food Science and Technology" scientific review of the Institute of Food Technologists (IFT) to be published in September 2010 issue of "Comprehensive Reviews in Food Science and Food Safety." It states that the review explores the role of food science and technology in nurturing the growing population of the world. It also accounts the potential application of biotechnology and nanotechnology in food technology.

The article discusses analytical techniques for characterization of biotechnology products and procedures in the U.S. It provides information on basic differences among biotechnology products from small molecule pharmaceuticals including size and complexity. It also describes the expression of protein products and explores regulatory differences and challenges of the biotechnology industry, specially during analysis of biopharmaceutical products.

The article reports on the move of the American Society of Mechanical Engineers (ASME) Codes and Standards to form a Bioprocessing Equipment (BPE) Committee, which is responsible for the installation, design and inspection of equipment used in the pharmaceutical and bioprocessing industries. It notes that BPE is an American National Standard that have become an adopted international standard that is used as a reference among 29 countries. It affirms that a new part of the standard also identifies the use of hygienic services and testing standards.

The article summarises the findings of a report focusing on how to put Great Britain in the strongest position to benefit from industrial biotechnology (IB) in a low carbon economy. Representatives from three working parties recommended the expansion of existing IB facilities and centres of expertise to develop and commercialise IB. They also provided solutions to potential IB barriers and recommended government actions.

The article defines the colours of biotechnology by providing choice case studies of how and why biotechnology is being applied. It offers information on the novel technological advances developed by several biotechnological firms including Green Biologics and Aquapharm and discusses their importance in various biological, chemical and industrial applications.

The article provides information on the initiation of biotechnology in South Africa. It states that the real push for biotechnology industry started in 2001, when the government presented a plan to switch from a resource-based economy to one based on knowledge. South Africa shows off the third-highest level of biodiversity in the world, and at least a one third of its plant is unique.

The article presents the top 10 technologies with potential effect to the environment and readers in the U.S. The new technology for the capture carbon dioxide (CO2) has been high in demand with national carbon control. Hyperion suggests carbon dioxide emissions may provide nuclear energy to neighborhoods of average-size American homes. Scientists in Japan work on design for massive floating power generators. Concern on the development of world to cut their emissions and fossil fuel use is one of the less-voiced challenges in greenhouse gas control.

The article focuses on using municipal solid waste and other waste stream to produce energy at base camps. For the military to use this technology, it should be scalable and modular. Modular and containerized systems usually consist of a solid waste management system, water purification system, and power generation system. Research in systems such as Tactical Garbage to Energy Refinery (TGER), biotechnologies, and pyrolytic gasification yields more protective solutions for clean energy.

The article focuses on synthetic biology, which aims to generate biofuels, medicines and novel organisms. It examines the advantages and disadvantages offered by synthetic biology. The article reveals that synthetic biology is now beginning to introduce the strategy of genetic modification into applications that traditional genetic engineering cannot reach.

The article reports that Dennis C. Liotta, an organic chemist at Emory University in Atlanta, Georgia, and colleagues have collaborated with South African government and scientific agencies to lay the foundation for a sustainable South African biotechnology industry. Liotta and his team are training a generation of South African scientists in the art of drug discovery and the business of getting those drugs onto the market.

The article discusses the use of radio identification systems (RFID) and sensor technologies in dairy farms in the U.S. It reveals that dairy farms are relying on a range of information technology systems to help improve health, breeding and milk production. Among the communications technologies being used by dairy farm operators include Bluetooth, Wi-Fi, wired Ethernet and RFID. Terry Smith, president and chief executive officer (CEO) of Dairy Strategies LLC, explained that the systems provide means for ongoing real-time monitoring of the performance of the business. Information on how the various technologies are implanted to a cow is also discussed. INSETS: RFID: Saving the World One Cow At a Time;Multiple Piercing;Cow: The Movie.